Monkeypox vaccination basics
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

Filetype[PDF-247.97 KB]


English
Details Supporting Files You May Also Like

Details:

  • Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
  • Description:
    Updated August 30, 2022

    In the U.S., two vaccines (JYNNEOS and ACAM2000) may be used to prevent monkeypox in the U.S. Monkeypox is caused by a virus that is closely related to the virus that causes smallpox. JYNNEOS was developed to protect against both monkeypox and smallpox. ACAM2000 was developed to protect against smallpox. Both vaccines are expected to provide a good level of protection against monkeypox.

    Vaccination is an important tool in preventing the spread of monkeypox. Because it’s not known how effective these vaccines will be in the current outbreak, people who are vaccinated are encouraged to continue to protect themselves from infection by avoiding close, skin-to-skin contact, including intimate contact, with someone who has monkeypox.

  • Content Notes:
    Who Should Get Vaccinated? -- Where You Can Get Vaccinated -- Vaccine Cost -- Vaccine Distribution -- Approved Vaccines.
  • Document Type:
    Webpage
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov